5 year follow-up results of the HERAKLES study: superior renal function after early conversion to an everolimus-based calcineurin inhibitor free regimen.

被引:0
|
作者
Sommerer, Claudia [1 ]
Budde, Klemens [1 ]
Arns, Wolfgang [1 ]
Reinke, Petra [1 ]
Guba, Markus [1 ]
Weithofer, Peter [1 ]
Vogt, Bruno [3 ]
Jacobi, Johannes [1 ]
Stahl, Rolf [1 ]
Rath, Thomas [1 ]
Hauser, Ingeborg A. [1 ]
Porstner, Martina [2 ]
May, Christoph [2 ]
Lehner, Frank [1 ]
Witzke, Oliver [1 ]
机构
[1] Herakles, Study Grp, Berlin, Germany
[2] Novartis, Pharma, Wehr, Germany
[3] Herakles, Study Grp, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P.1528
引用
收藏
页码:S724 / S724
页数:1
相关论文
共 50 条
  • [1] 5-YEAR FOLLOW-UP RESULTS OF THE HERAKLES STUDY: SUPERIOR RENAL FUNCTION AFTER EARLY CONVERSION TO AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN
    Lehner, F.
    Guba, M.
    Sommerer, C.
    Stahl, R.
    Vogt, B.
    Hauser, I.
    Reinke, P.
    Jacobi, J.
    Weithofer, P.
    Rath, T.
    Junge, M.
    Arns, W.
    Budde, K.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 35 - 35
  • [2] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 24
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    May, C.
    Baeumer, D.
    Paulus, E.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 310 - 311
  • [3] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    Baeumer, D.
    Sieder, C.
    Paulus, E.
    Witzke, O.
    [J]. TRANSPLANTATION, 2014, 98 : 81 - 81
  • [4] SUPERIOR RENAL FUNCTION IN AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND REDUCED CYCLOSPORINE/EVEROLIMUS: FOLLOW-UP OF THE HERAKLES STUDY AT MONTH 48
    Witzke, O.
    Rath, T.
    Weithofer, P.
    Guba, M.
    Jacobi, J.
    Hauser, I. A.
    Vogt, B.
    Stahl, R.
    Porstner, M.
    Reinke, P.
    Zeier, M.
    Lehner, F.
    Arns, W.
    Budde, K.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 23 - 23
  • [5] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 48
    Budde, K.
    Sommerer, C.
    Weithofer, P.
    Witzke, O.
    Guba, M.
    Jacobi, J.
    Vogt, B.
    Hauser, I.
    Stahl, R.
    Reinke, P.
    Rath, T.
    Baeumer, D.
    Porstner, M.
    Zeier, M.
    Lehner, F.
    Arns, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [6] SUPERIOR RENAL FUNCTION IN AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND LOW CYCLOSPORINE/EVEROLIMUS: FOLLOW-UP OF THE HERAKLES STUDY AT MONTH 36
    Guba, M.
    Budde, K.
    Sommerer, C.
    Neumayer, H. -H.
    Lehner, F.
    Reinke, P.
    Hauser, I. A.
    Weithofer, P.
    Rath, T.
    Baeumer, D.
    Porstner, M.
    Jacobi, J.
    Zeier, M.
    Witzke, O.
    Arns, W.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 22
  • [7] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36.
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    Baeumer, D.
    Sieder, C.
    Paulus, E.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 81 - 81
  • [8] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study
    Witzke, O.
    Budde, K.
    Lehner, F.
    Zeier, M.
    Neumayer, H. H.
    Stangl, M.
    Jacobi, J.
    Weithofer, P.
    May, C.
    Paulus, E. -M
    Arns, W.
    Sommerer, C.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 993 - 993
  • [9] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study
    Budde, K.
    Witzke, O.
    Lehner, F.
    Zeier, M.
    Neumayer, H. -H.
    Stangl, M.
    Jacobi, J.
    Kliem, V.
    May, C.
    Paulus, E. -M.
    Arns, W.
    Sommerer, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 41 - 41
  • [10] FOLLOW-UP DATA FROM HERAKLES STUDY AT MONTH 24: MAINTAINED SUPERIOR RENAL FUNCTION IN PATIENTS ON AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND LOW CYCLOSPORINE/EVEROLIMUS
    Lehner, F.
    Guba, M.
    Arns, W.
    Sommerer, C.
    Neumayer, H-H
    Jacobi, J.
    Weithofer, P.
    May, C.
    Baeumer, D.
    Paulus, E-M
    Witzke, O.
    Zeier, M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 28 - 28